# Stryker Corp: filings

SYK · NYSE · CIK 310764 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/syk.md) · [Financials](/companies/syk/financials.md) · [Filings](/companies/syk/filings.md) · [Insiders](/companies/syk/insiders.md)

## Reports and events: 318 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1577, 8-K 207, SC 13G/A 67, 10-Q 54, 3 40, 144 39, SC TO-T/A 33, 424B5 28, DEFA14A 20, 10-K 18, 4/A 18, DEF 14A 18, FWP 17, SC 13G 15, UPLOAD 15, 3/A 13, SD 13, SC TO-C 11, CORRESP 10, SC 13D/A 9, 5 7, S-3ASR 6, ARS 5, IRANNOTICE 5, SC 13D 5, SC TO-T 5, 424B3 4, 8-A12B 4, CERT 4, S-8 4, 10-Q/A 3, 25-NSE 3, SCHEDULE 13G/A 3, 424B2 2, 8-K/A 2, 10-K/A 1, PRE 14A 1, S-8 POS 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1, SD/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 11:08 ET | [10-Q](/filings/0000310764-26-000061.md) | Quarterly report, period 2026-09-30 | 0000310764-26-000061 |
| 2026-10-29 | 16:11 ET | [8-K](/filings/0000310764-26-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-26-000059 |
| 2026-10-06 | 08:08 ET | [8-K](/filings/0001193125-26-414956.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-414956 |
| 2026-07-31 | 11:41 ET | [10-Q](/filings/0000310764-26-000050.md) | Quarterly report, period 2026-06-30 | 0000310764-26-000050 |
| 2026-07-30 | 16:09 ET | [8-K](/filings/0000310764-26-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-26-000048 |
| 2026-06-26 | 15:45 ET | [8-K](/filings/0000310764-26-000041.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000310764-26-000041 |
| 2026-05-20 | 16:21 ET | [8-K](/filings/0001193125-26-232643.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-232643 |
| 2026-05-11 | 11:10 ET | [10-Q](/filings/0000310764-26-000031.md) | Quarterly report, period 2026-03-31 | 0000310764-26-000031 |
| 2026-05-08 | 13:02 ET | [8-K](/filings/0000310764-26-000029.md) | 5.07 Shareholder vote results | 0000310764-26-000029 |
| 2026-04-30 | 16:07 ET | [8-K](/filings/0000310764-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-26-000025 |
| 2026-04-14 | 12:59 ET | [SCHEDULE 13D/A](/filings/0001242914-26-000005.md) | Ownership report, active investor, amended | 0001242914-26-000005 |
| 2026-04-09 | 16:05 ET | [8-K/A](/filings/0001193125-26-149607.md) | 1.05 Material cybersecurity incident; 7.01 Regulation FD disclosure | 0001193125-26-149607 |
| 2026-03-23 | 13:05 ET | [DEF 14A](/filings/0000310764-26-000013.md) | Proxy statement, period 2026-05-06 | 0000310764-26-000013 |
| 2026-03-23 | 08:30 ET | [8-K](/filings/0001193125-26-118634.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-118634 |
| 2026-03-12 | 17:09 ET | [8-K](/filings/0001193125-26-104431.md) | 7.01 Regulation FD disclosure | 0001193125-26-104431 |
| 2026-03-11 | 17:24 ET | [8-K](/filings/0001193125-26-102460.md) | 8.01 Other events | 0001193125-26-102460 |
| 2026-02-11 | 11:43 ET | [10-K](/filings/0000310764-26-000010.md) | Annual report, period 2025-12-31 | 0000310764-26-000010 |
| 2026-01-29 | 16:11 ET | [8-K](/filings/0000310764-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-26-000006 |
| 2025-12-04 | 16:16 ET | [8-K](/filings/0001193125-25-308097.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-308097 |
| 2025-10-31 | 10:39 ET | [10-Q](/filings/0000310764-25-000129.md) | Quarterly report, period 2025-09-30 | 0000310764-25-000129 |
| 2025-10-30 | 16:15 ET | [8-K](/filings/0000310764-25-000126.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-25-000126 |
| 2025-08-01 | 12:09 ET | [10-Q](/filings/0000310764-25-000107.md) | Quarterly report, period 2025-06-30 | 0000310764-25-000107 |
| 2025-07-31 | 16:12 ET | [8-K](/filings/0000310764-25-000103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-25-000103 |
| 2025-05-13 | 17:29 ET | [8-K](/filings/0000310764-25-000085.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000310764-25-000085 |
| 2025-05-02 | 11:35 ET | [10-Q](/filings/0000310764-25-000075.md) | Quarterly report, period 2025-03-31 | 0000310764-25-000075 |
| 2025-05-01 | 16:10 ET | [8-K](/filings/0000310764-25-000072.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-25-000072 |
| 2025-03-25 | 13:16 ET | [DEF 14A](/filings/0000310764-25-000051.md) | Proxy statement, period 2025-05-08 | 0000310764-25-000051 |
| 2025-02-27 | 16:30 ET | [8-K](/filings/0001193125-25-039302.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-039302 |
| 2025-02-19 | 08:52 ET | [8-K](/filings/0001193125-25-029187.md) | 2.01 Completion of an acquisition or disposition | 0001193125-25-029187 |
| 2025-02-12 | 11:47 ET | [10-K](/filings/0000310764-25-000023.md) | Annual report, period 2024-12-31 | 0000310764-25-000023 |
| 2025-02-10 | 16:17 ET | [8-K](/filings/0001193125-25-023593.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-023593 |
| 2025-02-10 | 16:15 ET | [8-K](/filings/0001193125-25-023587.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-023587 |
| 2025-01-28 | 16:33 ET | [8-K](/filings/0001193125-25-014415.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-014415 |
| 2025-01-28 | 16:07 ET | [8-K](/filings/0000310764-25-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-25-000005 |
| 2025-01-07 | 06:58 ET | [8-K](/filings/0001193125-25-002537.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-002537 |
| 2024-10-30 | 12:35 ET | [10-Q](/filings/0000310764-24-000115.md) | Quarterly report, period 2024-09-30 | 0000310764-24-000115 |
| 2024-10-29 | 16:09 ET | [8-K](/filings/0000310764-24-000113.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-24-000113 |
| 2024-09-11 | 16:30 ET | [8-K](/filings/0001193125-24-217275.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-217275 |
| 2024-07-31 | 10:51 ET | [10-Q](/filings/0000310764-24-000098.md) | Quarterly report, period 2024-06-30 | 0000310764-24-000098 |
| 2024-07-30 | 16:09 ET | [8-K](/filings/0000310764-24-000095.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-24-000095 |
| 2024-05-14 | 16:43 ET | [8-K](/filings/0000310764-24-000081.md) | 5.07 Shareholder vote results | 0000310764-24-000081 |
| 2024-05-01 | 11:52 ET | [10-Q](/filings/0000310764-24-000064.md) | Quarterly report, period 2024-03-31 | 0000310764-24-000064 |
| 2024-04-30 | 16:11 ET | [8-K](/filings/0000310764-24-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-24-000062 |
| 2024-03-26 | 14:41 ET | [DEF 14A](/filings/0000310764-24-000054.md) | Proxy statement, period 2024-05-09 | 0000310764-24-000054 |
| 2024-02-14 | 10:55 ET | [10-K](/filings/0000310764-24-000024.md) | Annual report, period 2023-12-31 | 0000310764-24-000024 |
| 2024-01-30 | 16:07 ET | [8-K](/filings/0000310764-24-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-24-000005 |
| 2023-12-11 | 16:16 ET | [8-K](/filings/0001193125-23-292590.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-23-292590 |
| 2023-12-08 | 16:54 ET | [8-K](/filings/0001193125-23-291773.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-291773 |
| 2023-11-03 | 11:23 ET | [10-Q](/filings/0000310764-23-000116.md) | Quarterly report, period 2023-09-30 | 0000310764-23-000116 |
| 2023-11-02 | 16:20 ET | [8-K](/filings/0000310764-23-000114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-23-000114 |

Page 1 of 7. [Older](/companies/syk/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 12:17 ET. No prices; not investment advice.